Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Total Liabilities: 2022-2024

Historic Total Liabilities for Immunocore Holdings (IMCR) over the last 3 years, with Dec 2024 value amounting to $648.8 million.

  • Immunocore Holdings' Total Liabilities fell 0.12% to $705.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $705.9 million, marking a year-over-year decrease of 0.12%. This contributed to the annual value of $648.8 million for FY2024, which is 184.36% up from last year.
  • Immunocore Holdings' Total Liabilities amounted to $648.8 million in FY2024, which was up 184.36% from $228.2 million recorded in FY2023.
  • Immunocore Holdings' 5-year Total Liabilities high stood at $648.8 million for FY2024, and its period low was $187.9 million during FY2022.
  • Its 3-year average for Total Liabilities is $354.9 million, with a median of $228.2 million in 2023.
  • Data for Immunocore Holdings' Total Liabilities shows a peak YoY surged of 184.36% (in 2024) over the last 5 years.
  • Over the past 3 years, Immunocore Holdings' Total Liabilities (Yearly) stood at $187.9 million in 2022, then increased by 21.45% to $228.2 million in 2023, then soared by 184.36% to $648.8 million in 2024.